Bj. Lippmann et al., PHARMACOLOGY OF VOLUME REGULATION FOLLOWING HYPOTONICITY-INDUCED CELLSWELLING IN CLONAL N1E115 NEUROBLASTOMA-CELLS, Brain research, 686(1), 1995, pp. 29-36
When exposed to hypotonic solutions, clonal N1E115 neuroblastoma cells
initially swell and later undergo a regulatory volume decrease (RVD).
We studied the effects of a variety of transport inhibitors on the ti
me course of cross-sectional area of N1E115 cells exposed to a solutio
n of reduced osmolarity (pi = 186 mosm). Application to the bath of ei
ther: (i) blockers of net K efflux through K channels (e.g. isotonic K
Cl or 20 mM TEA); or (ii) blockers of net efflux through anion channel
s (e.g. isotonic methanesulfonate, 10 mu M DIDS or 100 mu M IAA-94) al
l prevent RVD. In contrast, ouabain (a Na+/K+ pump blocker), bumetanid
e (a Na+/K+/Cl- cotransporter blocker) and SITS (a HCO3-/Cl- exchange
blocker) do not. These data support the involvement of these channels
over pumps or exchangers in solute exit during RVD. Only variable bloc
k of RVD was achieved using blockers of stretch activated non-selectiv
e cation C+(SA) channels (i.e., amiloride and gadolinium, Gd3+) or a m
embrane permeant Ca chelator (BAPTA-AM) suggesting that neither the op
ening of C+(SA) channels nor a global rise in cytosolic Ca2+ is critic
al for triggering RVD.